RecallRadar

FDA Drug recall D-1279-2014

Fluoxetine Capsules, USP, 20 mg, 30-count bottles, Rx only, Distributed by: Wal-Mart, Bentonville, AR 72716

On 2014-05-07 the FDA classified a Class II recall of Fluoxetine Capsules, USP, 20 mg, 30-count bottles, Rx only, Distributed by: Wal-Mart, Bentonville, AR 72716 by Legacy Pharmaceutical Packaging, citing chemical Contamination: The recalling firm received notice that their supplier is recalling capsules due to complaints of capsules having an unusual odor.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-1279-2014
ClassificationClass II
Statusterminated
Initiated2014-02-14
Published2014-05-07
Last updated2026-09-13 11:51 UTC
CompanyLegacy Pharmaceutical Packaging
DistributionUS

Product

Fluoxetine Capsules, USP, 20 mg, 30-count bottles, Rx only, Distributed by: Wal-Mart, Bentonville, AR 72716; Manufactured by: TEVA PHARMACEUTICALS USA, Sellersville, PA 18960; Packaged by: Legacy Pharmaceutical Packaging LLC, Earth City, MO 63045, NDC 68645-130-54, UPC 3 68645 13054 5.

Reason

Chemical Contamination: The recalling firm received notice that their supplier is recalling capsules due to complaints of capsules having an unusual odor.

Identifiers

upc368645130545
ndc68645-131-54
ndc68645-130-54
code_infoLot numbers: 131328, Exp 08/15; 131634, Exp 09/15; and 131833, Exp 11/15

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1279-2014%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.